Lucy Fisher @lucyfisher.ft.com Whitehall editor at the Financial Times 🗞️
Host of the FT’s award-winning ‘Political Fix’ podcast🎙️Author 📚
Fiona J Whelan @whelanfj.bsky.social Senior Lecturer, Lister Prize Fellow, & UKRI Future Leaders Fellow at U of Manchester. Bioinf, microbes, evol bio, running, cycling, & pub chats. she/her 🇨🇦. whelanlab.co.uk
Amber Cutcliffe @ambercutcliffe.bsky.social First-year BBSRC NWD PhD student | Exploring how commensal bacteria modulate Pseudomonas aeruginosa virulence in the CF lung.
Louise Flanagan @flanagella.bsky.social Research Associate in AMR Evolution at the University of Manchester. And I have a life too, I swear. She/her ☘️
PULSE-CF Research Innovation Hub @pulse-cf.bsky.social Research programme funded by the Cystic Fibrosis (CF) Trust and LifeArc and hosted by University of Manchester. We are doctors and scientists looking to better understand CF exacerbations and improve the lives of people with CF.
www.pulse-cf.com
plasmidsaurus @plasmidsaurus.bsky.social Sequence plasmids, amplicons, colonies, AAV, yeast, and bacterial genomes! Our advanced sequencing delivers comprehensive visibility, higher accuracy, and the ability to detect structural variations and rare mutations that other sequencing methods miss.
Rebecca Wallis D @rebeccawallis.bsky.social 📍 UoM PhD in Microbiology in the Whelan Lab
BIST MSc at CRG institute https://pyrisentinel.eu
Harry Smith Studentship in the Whelan lab
BSc Biotech & CompSc at UoNottingham
Pangenome, metagenomics, microbiome 🧬🧫
She/Her
EMJ GOLD @emg-gold.com The latest pharma news, views and analysis.
Sign up to our mailing list to receive insights direct to your inbox: https://emjreviews.com/mailing-list/
Symbiosky @symbiosky.bsky.social Make Decisions Through Conviction,
Fund Public Good like Journalism, Academic Content, Education
https://www.symbiosky.com/
TeselaGen Biotechnology @teselagen.bsky.social The AI-enabled operating system for biotechnology: https://teselagen.com/
Life Science Network @lifesciencenet.bsky.social A platform for life sciences. Publications, research protocols, news, events, jobs and more. Sign up at https://www.lifescience.net.
40:40 Recruitment - celia@4040recruitment.co.uk @4040rec.bsky.social We are a Specialist Recruitment Partner within the Pharma, Healthcare, Medical Devices & MedTech arenas throughout UK & Ireland. We cover all levels of roles in Commercial, Sales, Market Access, Market Research, Marketing, People Management & Medical
Marsh Equity Research @marshequity.bsky.social We find companies trading below their intrinsic value and share them via an email newsletter.
Subscribe here: marshequityresearch.substack.com- E Emma Lake @emmaladyofthelake.bsky.social
The Museum of English Rural Life (MERL) @themerl.bsky.social We explore the history of the English countryside and its people. Chaotic Good.
https://merl.reading.ac.uk/
The New Yorker @newyorker.com Unparalleled reporting and commentary on politics and culture, plus humor and cartoons, fiction and poetry. Get our Daily newsletter: http://nyer.cm/gtI6pVM
Follow The New Yorker’s writers and contributors: https://go.bsky.app/Gh5bFwS
Tiffany Timbers @tiffanytimbers.bsky.social Associate Professor of Teaching in Statistics, Master of Data Science program Instructor, UBC, Vancouver, Canada | she/her
Neal Hudson @resi-analyst.bsky.social UK housing market analyst. Personal account.
Analysis and commentary at https://builtplace.com/
Visiting Fellow at Henley Business School.
Columnist for FT Weekend’s Money.
Hugging Face @hf.co The AI community building the future! 
pharmaphorum @pharmaphorum.bsky.social pharmaphorum.com, and its magazine Deep Dive, is a leading online destination for pharmaceutical industry and healthcare news, insight, and debate
Steven Tait @stevent8.bsky.social 
Cystic Fibrosis Trust @cysticfibrosis.org.uk We're dedicated to uniting for a life unlimited for those living with cystic fibrosis. Our social & Helpline teams monitor our accounts between 9-5 weekdays.
cysticfibrosis.org.uk
@kjaganatha.bsky.social @kjaganatha.bsky.social 
Stephen Turner @stephenturner.us FIeld guide. Quartermaster. Associate Professor and Research Dean at UVA School of Data Science. Views my own.
Web: https://datascience.virginia.edu/people/stephen-turner
Newsletter: https://blog.stephenturner.us
Robert Smith @bondhack.ft.com Financial Investigations Editor at the Financial Times.
Have a tip? Email: robert.smith@ft.com / robert.smith.ft@proton.me | Signal: robert_smith_ft.55
Financial Times @financialtimes.com The best of FT journalism, including breaking news and analysis.
https://www.ft.com
The users this account follows are verified FT staff or contributors.
BioIndustry Association (BIA) @bia-uk.bsky.social The award-winning UK trade association for the innovative life sciences and biotech industry.
Derek Lowe @dereklowe.bsky.social Medicinal chemist / chemical biologist, author of “In the Pipeline” at http://science.org/blogs/pipeline. derekb.lowe@gmail.com and on Signal at Dblowe.18
All opinions are mine; I don’t speak for my employer in any way.
STAT @statnews.com Reporting from the frontiers of health & medicine.
Explore all of our newsletters here: https://www.statnews.com/signup/
Pearl Freier @pearlf.bsky.social From Boston, MA. I'm @pearlf on the other blue-colored place. Founder of Cambridge BioPartners, Inc. I post mostly healthcare-related and biotech-related news items. 
Bob More @bobmore.bsky.social Curious.
Biotech, outdoors, skiing, hiking, global health, venture capital, entrepreneurship.
Richard Wilson @richardwilson.bsky.social From the UK to the SF Bay | AAV Biotech, cycling, empty nesting
Sally Church @maverickny.bsky.social Scientist, cancer geek, journalist, Londoner, always curious, adventurer, explorer, immigrant, lover of curry, fine wine & football
Bijan Salehizadeh @bijans.bsky.social Healthcare investor. Howard Stern. Arcade Fire. Bowie. U2. California dreamin'
Imran S. Haque @ihaque.bsky.social CTO at Kimia Therapeutics. Formerly SVP AI at Recursion.
https://ihaque.org
https://x.com/ImranSHaque
Patrick Malone @pmalone.bsky.social physician-scientist, biotech/healthcare investor @ KdT Ventures
Mike Thompson, MD, PhD, FASCO @mtmdphd.bsky.social Views my own. VP Clinical Partnerships @TempusAI
#PrecisionMedicine #mmsm #lymsm #CCC19 @COVID19nCCC @ASCO COI: https://coi.asco.org/share/RBB-TT6R/Michael
Bruce Booth @lifescivc.bsky.social Early stage biotech VC. Recovering scientist.
Opinions expressed are solely my own and do not express the views or opinions of Atlas Venture.
Peter Kolchinsky @peterkolchinsky.bsky.social Biotech investor. Virologist. Author: The Great American Drug Deal. Founder: No Patient Left Behind. Healthcare reform advocate. Daughter says I’m cool 75% of the time; son says 100%.
Sifted @sifted.eu The leading media brand empowering startup Europe.
Read our articles here: https://sifted.eu/latest
Subscribe to our newsletter: https://sifted.eu/newsletters
Michael Gilman @gilman.bsky.social Scientist, entrepreneur, ex-biopharm exec, former FM radio jock, lifelong hockey fan, aspiring guitar player and mixologist, #immigrant. CEO, Arrakis Therapeutics and a variety of other things. https://www.michaelgilman.net/disclosures/
Simon Bayly @simonbayly.bsky.social Reformed chemist 👨🔬 IP licensing and spinouts at the Francis Crick Institute. Also post about cycling 🚲 Opinion my own etc.
Drew Armstrong @drewsnews.bsky.social Endpoints News executive editor -- where the business of medicine gets answers. Posts on biotech, pharma, drugs, financial markets science and business (and how they all intersect). #biosky
Priors: Bloomberg News + the Covid vaccine tracker. CQ.
Lisa Jarvis @lisamjarvis.bsky.social Chicago-based health & science columnist for Bloomberg Opinion @opinion.bsky.social. Writing about public health, medicine, emerging technologies (Crispr!), biotech & pharma. opinions=mine, She/her. Signal: lisajarvis.77
Michael Wong @michaelwong.bsky.social Biotech venture creation and pharma partnerships. Company builder by practice, placental biologist by training. 🇨🇦
SynBioBeta @synbiobeta.bsky.social Synthetic Biology Events & Industry Information
🌍 Global Synthetic Biology Conference
📅 May 5-8, 2025 in San Jose
Join us! #SynBioBeta2025
https://www.synbiobeta.com/events/synbiobeta-2025
David Sable @dbsable.bsky.social Doctor/teacher/writer. Ob/gyn and IVF doc. Roadie for Priya Mayadas.
Adjunct @Columbia https://dbsable.substack.com
Nooman Haque @noomanhaque.bsky.social Investor in life sciences & tech. Innovation policy. Fellow at Cambridge University. Married to a better economist. Cooking. Sports, but badly. ICI was the perfect company once
David Shaywitz @dshaywitz.bsky.social MD/PhD Exec | Biomedical innovation ∩ tech | Advising innovators at the tech/biopharma R&D interface, attuned to nuances of science as well as org culture | Chief Med Scientist, Lore: tools for agency+health | DBMI | AEI. | davidshaywitz.com
Zachary Brennan @zacharybrennan.bsky.social Senior editor, Endpoints News
Rich Law @drrichjlaw.bsky.social Chief Business Officer of Haya Therapeutics! (formerly Exscientia/Recursion CBO), computational chemist by training (Oxford, UCSD, LLNL & Evotec), bike racer, ex-Oxford rower & LFC fan! #YNWA.
Frank S. David @franksdavid.bsky.social Biotech R&D strategy @ Pharmagellan. Prof of Practice of Biotech @ Tufts Biology. Bio, books, blog & more at www.pharmagellan.com. #biosky
Jeff Cranmer @jcranmer.bsky.social Executive Editor, BioCentury. Host, BioCentury This Week biotech podcast. Jersey Boy happily ensconced in Cali. Princeton. SAIS. Philly Eagles. Opinions=my own.
Adam Feuerstein✡️ @adamfeuerstein.bsky.social Reporter at STAT. The Harry Kane of biotech. Dog ❤️er. Polk Award winner. Said one analyst: The likes of Adam Feuerstein attack viciously.
Nathan Miller @nmiller.bsky.social Drug Discovery Fellow @ DE Shaw Research
Comp chem, biological/protein engineering, viruses
Past: PhD ‘22 MIT HST, ‘17 Harvey Mudd
Antonio Regalado @antonioregalado.bsky.social Journalist covering biotechnology for MIT Technology Review. Scoops about new methods in genetics and cell biology. The "playing God" beat. Gene editing, gene therapy, ancient DNA, synthetic embryos, cloning, etc. 
Tyler Gibson @tgibs.bsky.social Molecular biologist with expertise in gene therapy and genome/epigenome editing. HoH. Research in the inner ear, hearing, and balance. That's my dog in the profile.
Malgorzata Rogalska @mrogalska.bsky.social Expert in RNA Biology & Therapeutics, Genetic Diseases, Gene Therapies & Cancer Research | Skilled in Data Analysis | Translating Cutting-Edge Science into Investment Opportunities
Jonas Verhellen @jonasverhellen.bsky.social Theoretical physicist with a PhD in neuroscience. Postdoc in protein-protein interactions. Into art, science, and innovation.
Currently: Copenhagen 🇩🇰
Previously: Oslo 🇳🇴, London 🇬🇧, Brussels 🇧🇪
Jeff Wintersinger @jwintersinger.bsky.social Senior Research Scientist in comp bio at @deepgenomics. Did PhD work on cancer evolution. My three favourite things are bananas, riding my bike very fast, and vim.
Luke Timmerman @luketimmerman.bsky.social Founder & Editor, Timmerman Report.
Breakout Ventures @breakout-ventures.bsky.social We partner with exceptional founders scaling scientific innovation to build the breakout companies powering our future. Learn more at breakout.vc
Ajay Mistry @ajaymistry.bsky.social Founder of Biotech (https://oppilotech.com/) oncology & infectious diseases. Expanding musical tastes….
Ben Fidler @benthefidler.bsky.social Biotech journalist; Senior Editor, BioPharma Dive. Former Deputy Biotech Editor, Xconomy. #BioSky
Ruben Sebastian @rubensebas.bsky.social Biotech investor, operator & BD | Drug development | EIR @mskcancercenter.bsky.social |📍New York
https://www.linkedin.com/in/rubensebastianperez/
Dr. Dave Scott @greaterscott.bsky.social Structural biology and Biophysics at the University of Nottingham and Research Complex at Harwell (UK).
Academic and writer of papers and grants with modest success.
Happy collaborator and always available to chat science.
He/him.
Marc Engelsgjerd @engelsgjerd.bsky.social Royalty Pharma, biotech, marathons, Crystal Palace
Max Gelman @maxgelman.bsky.social Reporting on pharma and biotech for Endpoints News. Baseball fan, Northwestern alum. Message me on Signal: maxgelman.37
Garrett Ginell, PhD @gginell.bsky.social Biotech VC - Boston. Building and investing in biotech and life science companies to drive patient impact and advance innovation.
Stephane Richard @gen2x.bsky.social Drug Discovery Catalyst and AMR Enthusiast
Max Bayer @maxbayer.bsky.social Pharma reporter at Endpoints News | Past: Fierce Biotech and CBS News | mbayer@endpointsnews.com or maxbayer.10 on Signal. he/him
BioPharmGuy @biopharmguy.bsky.social We keep track of all the biotech companies. And write a pretty fun weekly newsletter.
Matthew Herper @matthewherper.bsky.social I write about medicine at STAT. This is biology's century. Every data point has a face.
Mindaugas Galvosas, MD @mgalvosas.bsky.social Neuroscience Digital Biomarkers @ indivi.io | prev. cough as a digital biomarker @ hyfe.com; founder of wandering prevention tech for dementia | interested in Digital Health | my opinions
Endpoints News @endpts.com We're where the business of medicine gets answers. An independent news media organization covering biotech, pharma, science, policy, finance, venture capital and markets, and how they drive the life sciences industry. Read us at www.endpts.com. 
Andrew Dunn @andrewedunn.bsky.social Reporter @ Endpoints News
Covering biotech, pharma, AI, and more — the future of medicine
adunn@endpointsnews.com
Jason Kelly @jasonrkelly.bsky.social co-founder and CEO at Ginkgo Bioworks
Former Chair of National Security Commission on Emerging Biotechnology
Harry Wilders @harrywilders.bsky.social GSK/Francis Crick Institute Industrial Post-Doctoral Researcher exploring chemoproteomics approaches to covalent drug discovery
EOMESbiotech @eomesbiotech.bsky.social Biotech & Lifescience Investor, Germany/Switzerland,
@zbiotech.bsky.social @zbiotech.bsky.social buy-side healthcare analyst, equity/debt and catalyst-driven focus...may have positions in names I discuss, opinions are my own
Art Krieg @artkrieg.bsky.social Love trail running, hiking, Toll-Like receptors 7/8/9, P1 pDC. Founder/CEO of Zola Therapeutics
Bruce Levine, Ph.D. 🇺🇦 @bllphd.bsky.social 🧬🧪Professor @Pennmedicine #CellTherapy #Genetherapy #Inventor #Kymriah #CARTCell @TmunityTx & @CapstanTx CoFounder, Past President @ISCTGlobal @PNASNexus AE
https://orcid.org/0000-0001-6971-8465
Becky Pferdehirt @beckypferdehirt.bsky.social Investor @a16zbiohealth 🧬. Previously BD, R&D @Amgen, R&D @Genentech. Proud alum of @Cal & @MIT. Girl mom. Coastsider.
Mark Lansdell @citelineml.bsky.social Citeline | Evaluate Consulting
@rebeccaphd.bsky.social @rebeccaphd.bsky.social VP, Global Commercial Strategy Lymphoma, Leukemia and Cell Therapy, Johnson & Johnson Innovative Medicine. Posts are my own.
Ryan Leenay @rtleenay.bsky.social Head of Gene Editing at Lilly.
“We cannot predict the future, but we can invent it” -Dennis Gabor
Likes and retweets are not endorsements.- B Mike Ward @biopharmamike.bsky.social Life sciences & healthcare thought leader with 40+ years experience as journalist and analyst covering issues consequential to biopharma and Medtech stakeholders
Simon Bornschein @simonbornschein.bsky.social CEO CodingBio | Machine learning meets biotech | Exploring cool science, startups, and progress in healthcare.
Susan Schaeffer @biotechsusan.bsky.social President & CEO of The Patients' Academy for Research Advocacy. Preparing and empowering patients to contribute their expertise to drug development, regulation & access. She/her.
Hannah Kuchler @hannahkuchler.bsky.social Global pharma editor @FT, leading science and pharma team. Emmy-nominated, Loeb winner. Previously NY, SF, HK. 
Sheila Ranganath @sheilaranganath.bsky.social SVP, Oncology and Immunology Portfolio Head and Program Leadership, Pioneering Medicines @ Flagship Pioneering
Nicole DeFeudis @nicoledefeudis.bsky.social Biopharma reporter at Endpoints News | nicole@endpointsnews.com
John Maraganore @jmaraganore.bsky.social Founding CEO of Alnylam Pharmaceuticals. RNAi therapeutics pioneer.
CEO and Principal of JMM Innovations, LLC. Committed to advancing biomedical innovation to patients.
David H. Crean @davidhcrean.bsky.social Venture Capital, General Partner @1004 Venture Partners | Investment Banking, Mergers & Acquisitions, Healthcare & Life Sciences| biotechnology, pharmaceuticals, medical technology and devices.
Richard Torbett @torbett.bsky.social Chief Executive at ABPI. Posting in a personal capacity
Rowan Gardner @rowanbio.bsky.social Founder & CBIO @precisionlife.bsky.social, NED at STFC Innovations Limited. Former Juror for Cartier Women's Initiative.
Interests #bio #diversity #ai #techbio #climate #precisionmedicine #digitalhealth personal account
Shashank Pant, PhD @spant18.bsky.social Sr. Scientific lead @ Eli Lilly | Computational chemist & biophysicist | PhD from @Illinois_Alma @tcbguiuc | Posts reflect my own views. 🇮🇳 | email- shashankpant.lko@gmail.com
Ogulcan @vogulcankaya.bsky.social full-stack molecular biologist. 3D Genome. DNA Repair. Comp Bio. currently PhD candidate in http://adebalilab.org
Louise Jefferies @louisejefferies.bsky.social Helping introverted scientists to speak up with confidence and become more visible without becoming overwhelmed. Learn to use your mental chatter as a constructive force rather than a destructive one. https://www.louisejefferies.com/
Bill Mowrey @billbio.bsky.social Principal Scientist at Alexion, AstraZeneca Rare Disease (views are my own)